Observational Study of the Sleuth Implantable ECG Monitoring System

Transoma Medical250 enrolled

Overview

The purpose of this study is to obtain information on real-world device performance clinical assessments and clinical outcomes of patients receiving the Sleuth Implantable ECG Monitoring System.

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Syncope Presyncope Fainting Cardiac Arrhythmia

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with clinical syndromes or situations at increased risk of cardiac arrhythmias * Patients who experience transient symptoms that may suggest a cardiac arrhythmia Exclusion Criteria: * Patients that have had a myocardial infarction (MI) \< 30 days prior to implant

Locations (8)

Piedmont Hospital

Atlanta, Georgia, United States

Western Maryland Health Systems

Cumberland, Maryland, United States

Cardiology Consultants of East Michigan

Lapeer, Michigan, United States

St. Luke's - Roosevelt

New York, New York, United States

Outcomes

Primary Outcomes

Time to diagnosis

Time frame: one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.